Integrated physical-bio platform for systemic disease management & yield enhancement

Methodology & Core Innovation: The ELPC (Electronic Life-Particle Conduction) platform is a disruptive non-chemical technology that utilizes low-frequency physical resonance to optimize plant health. Our system performs a dual-action role:

Source Blockage: It effectively repels disease vectors such as Psyllids and Fruit Flies, severing the transmission chain of pathogens.

Systemic Treatment: It facilitates the deep penetration of a Herbal Extract + Microbial synergetic system into the plant's vascular tissues, reaching internal infections that traditional chemical sprays cannot access.

Metrics & Validation: Our technology is validated at TRL 6 through extensive field trials (GAFCs 2026). Key performance metrics include:

Yield Enhancement: Consistently achieved >20% increase in biomass and crop yield in systemic trials (e.g., Citrus and Solanaceae).

Disease Management: Proven high efficacy in treating "incurable" diseases such as Citrus HLB (Huanglongbing), Bacterial Wilt, and Root Rot.

Sustainability: 100% non-toxic with zero chemical residues, ensuring crops meet the highest international export standards.

Next Steps & Collaboration: We are seeking strategic partners for Co-development and Licensing to scale the ELPC platform globally. Our validation plan involves expanding pilot engagements in diverse geographical regions (e.g., South America and SE Asia) to further demonstrate the platform’s adaptability across various climate zones and soil types.

Intellectual Property (IP) Protection: We have formally applied for Patents and Trademarks in Australia, securing the intellectual property rights for our ELPC physical-conduction algorithms and specialized herbal-microbial formulations. This underscores our commitment to maintaining high international standards and protecting our strategic partners' interests during global commercialization.